PortfoliosLab logoPortfoliosLab logo
PRLB vs. HCSG
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PRLB vs. HCSG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Proto Labs, Inc. (PRLB) and Healthcare Services Group, Inc. (HCSG). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PRLB achieves a 47.60% return, which is significantly higher than HCSG's 5.60% return. Over the past 10 years, PRLB has outperformed HCSG with an annualized return of 1.02%, while HCSG has yielded a comparatively lower -4.65% annualized return.


PRLB

1D
-4.58%
1M
16.06%
YTD
47.60%
6M
45.90%
1Y
98.80%
3Y*
31.31%
5Y*
-3.31%
10Y*
1.02%

HCSG

1D
-0.25%
1M
-4.36%
YTD
5.60%
6M
7.34%
1Y
42.99%
3Y*
13.20%
5Y*
-6.35%
10Y*
-4.65%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PRLB vs. HCSG - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
PRLB
Proto Labs, Inc.
47.60%29.42%0.33%52.60%-50.28%-66.53%51.06%-9.97%9.50%100.58%
HCSG
Healthcare Services Group, Inc.
5.60%64.61%12.01%-13.58%-28.66%-34.56%19.52%-37.76%-22.39%36.77%

Correlation

The correlation between PRLB and HCSG is 0.41, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.41

Correlation (3Y)
Calculated over the trailing 3-year period

0.44

Correlation (5Y)
Calculated over the trailing 5-year period

0.40

Correlation (10Y)
Calculated over the trailing 10-year period

0.38

Correlation (All Time)
Calculated using the full available price history since Feb 27, 2012

0.34

Fundamentals

Market Cap

PRLB:

$1.81B

HCSG:

$1.43B

EPS

PRLB:

$1.06

HCSG:

$0.94

PE Ratio

PRLB:

70.27

HCSG:

21.53

PS Ratio

PRLB:

3.31

HCSG:

0.79

PB Ratio

PRLB:

2.65

HCSG:

2.34

Total Revenue (TTM)

PRLB:

$546.26M

HCSG:

$1.85B

Gross Profit (TTM)

PRLB:

$245.03M

HCSG:

$251.34M

EBITDA (TTM)

PRLB:

$60.04M

HCSG:

$88.48M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PRLB vs. HCSG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PRLB
PRLB Risk / Return Rank: 9191
Overall Rank
PRLB Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
PRLB Sortino Ratio Rank: 9292
Sortino Ratio Rank
PRLB Omega Ratio Rank: 9090
Omega Ratio Rank
PRLB Calmar Ratio Rank: 9191
Calmar Ratio Rank
PRLB Martin Ratio Rank: 9292
Martin Ratio Rank

HCSG
HCSG Risk / Return Rank: 7373
Overall Rank
HCSG Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
HCSG Sortino Ratio Rank: 7272
Sortino Ratio Rank
HCSG Omega Ratio Rank: 6969
Omega Ratio Rank
HCSG Calmar Ratio Rank: 7676
Calmar Ratio Rank
HCSG Martin Ratio Rank: 7676
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PRLB vs. HCSG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Proto Labs, Inc. (PRLB) and Healthcare Services Group, Inc. (HCSG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PRLBHCSGDifference

Sharpe ratio

Return per unit of total volatility

2.22

0.97

+1.25

Sortino ratio

Return per unit of downside risk

3.50

1.83

+1.66

Omega ratio

Gain probability vs. loss probability

1.44

1.23

+0.21

Calmar ratio

Return relative to maximum drawdown

5.09

2.17

+2.92

Martin ratio

Return relative to average drawdown

14.93

5.51

+9.42

PRLB vs. HCSG - Sharpe Ratio Comparison

The current PRLB Sharpe Ratio is 2.22, which is higher than the HCSG Sharpe Ratio of 0.97. The chart below compares the historical Sharpe Ratios of PRLB and HCSG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


PRLBHCSGDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.22

0.97

+1.25

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.07

-0.15

+0.09

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.02

-0.12

+0.14

Sharpe Ratio (All Time)

Calculated using the full available price history

0.15

0.21

-0.06

Drawdowns

PRLB vs. HCSG - Drawdown Comparison

The maximum PRLB drawdown since its inception was -91.22%, which is greater than HCSG's maximum drawdown of -81.04%. Use the drawdown chart below to compare losses from any high point for PRLB and HCSG.


Loading charts...

Drawdown Indicators


PRLBHCSGDifference

Max Drawdown

Largest peak-to-trough decline

-91.22%

-81.04%

-10.18%

Max Drawdown (1Y)

Largest decline over 1 year

-19.51%

-19.88%

+0.37%

Max Drawdown (3Y)

Largest decline over 3 years

-35.14%

-39.96%

+4.82%

Max Drawdown (5Y)

Largest decline over 5 years

-77.19%

-70.47%

-6.72%

Max Drawdown (10Y)

Largest decline over 10 years

-91.22%

-81.04%

-10.18%

Current Drawdown

Current decline from peak

-70.31%

-57.31%

-13.00%

Average Drawdown

Average peak-to-trough decline

-43.22%

-32.00%

-11.22%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.64%

7.82%

-1.18%

Volatility

PRLB vs. HCSG - Volatility Comparison

Proto Labs, Inc. (PRLB) has a higher volatility of 10.09% compared to Healthcare Services Group, Inc. (HCSG) at 9.41%. This indicates that PRLB's price experiences larger fluctuations and is considered to be riskier than HCSG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PRLBHCSGDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.09%

9.41%

+0.68%

Volatility (6M)

Calculated over the trailing 6-month period

33.26%

33.04%

+0.22%

Volatility (1Y)

Calculated over the trailing 1-year period

44.85%

44.66%

+0.19%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

50.45%

42.06%

+8.39%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

47.93%

40.49%

+7.44%

Dividends

PRLB vs. HCSG - Dividend Comparison

Neither PRLB nor HCSG has paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
HCSG
Healthcare Services Group, Inc.
0.00%0.00%0.00%0.00%7.10%4.68%2.89%3.26%1.92%1.43%1.87%2.04%
PRLB
Proto Labs, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

PRLB vs. HCSG - Financials Comparison

This section allows you to compare key financial metrics between Proto Labs, Inc. and Healthcare Services Group, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


100.00M200.00M300.00M400.00M500.00M20222023202420252026
139.34M
462.77M
(PRLB) Total Revenue
(HCSG) Total Revenue
Values in USD except per share items

PRLB vs. HCSG - Profitability Comparison

The chart below illustrates the profitability comparison between Proto Labs, Inc. and Healthcare Services Group, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%10.0%20.0%30.0%40.0%50.0%20222023202420252026
45.6%
16.4%
Portfolio components
PRLB - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Proto Labs, Inc. reported a gross profit of 63.59M and revenue of 139.34M. Therefore, the gross margin over that period was 45.6%.

HCSG - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Healthcare Services Group, Inc. reported a gross profit of 75.83M and revenue of 462.77M. Therefore, the gross margin over that period was 16.4%.

PRLB - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Proto Labs, Inc. reported an operating income of 9.84M and revenue of 139.34M, resulting in an operating margin of 7.1%.

HCSG - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Healthcare Services Group, Inc. reported an operating income of 33.84M and revenue of 462.77M, resulting in an operating margin of 7.3%.

PRLB - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Proto Labs, Inc. reported a net income of 8.11M and revenue of 139.34M, resulting in a net margin of 5.8%.

HCSG - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Healthcare Services Group, Inc. reported a net income of 26.06M and revenue of 462.77M, resulting in a net margin of 5.6%.


Frequently Asked Questions


PRLB and HCSG have a correlation of 0.41, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PRLB has higher volatility (10.09%) compared to HCSG (9.41%). In terms of maximum drawdown, PRLB dropped -91.22% vs HCSG's -81.04%.

PRLB currently has the higher Sharpe Ratio (2.22 vs 0.97), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PRLB and HCSG

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer